AKT1 and Hepatic steatosis: To explore the mechanism underlying improved hepatic steatosis and glycemic traits in Slc39a5-/- mice we evaluated two key signaling hubs that mediate lipid metabolism and insulin sensitivity, AMPK and AKT.